Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. reports developments tied to its national home health and hospice care business in the United States. The company’s Home Health segment provides Medicare-certified nursing, therapy, medical social work and aide services for adult patients, while its Hospice segment focuses on care for patients with life-limiting illnesses.
Recurring Enhabit news includes quarterly operating results, home health admissions and census trends, hospice performance, debt reduction and credit-related actions, investor presentations, material agreements, shareholder voting matters and governance updates. Company updates also cover legal and regulatory disclosures when they affect its public-company reporting or corporate matters.
Enhabit Home Health & Hospice has successfully completed its spin-off from Encompass Health Corporation, now trading under the ticker symbol EHAB on the NYSE as of July 1, 2022. The company emphasizes its commitment to providing high-quality in-home patient care while leveraging over 20 years of expertise. It operates across 351 locations in 34 states. Additionally, Enhabit appointed Tina L. Brown-Stevenson and Susan A. La Monica to its board, enhancing strategic capabilities. The spin-off allows for greater operational flexibility and focus on patient and investor interests.
Encompass Health Corporation has successfully completed the spin-off of its home health and hospice business, Enhabit, Inc., as of July 1, 2022. Each Encompass Health stockholder received one share of Enhabit common stock for every two shares held by the close of business on June 24, 2022. This transaction is structured to be tax-free for shareholders, except for cash received for fractional shares. Enhabit will begin trading on the NYSE under the symbol 'EHAB,' while Encompass Health continues to trade under 'EHC.'